Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2011
INTERVENTION: 1:Testosterone Undecanoate Capsule;2:Placebo; CONDITION: Late Onset Hypogonadism PRIMARY OUTCOME: SF‐12; INCLUSION CRITERIA: Subjects were men at least 50 years of age with symptoms of androgen deficiency which was indicated by a positive score on androgen deficiency in aging males (ADAM) questionnaire as well as total morning testosterone measurement of <8nmol/L (230ng/dL), or free testosterone level <225pmol/L (65pg/mL) if the serum total testosterone level is between 8 and 12nmol/L
Epistemonikos ID: 57a7cf28205db18e8dca7d91754eba845a1e9cbf
First added on: Aug 22, 2024